Print this Page
Research at Fox Chase
A Century of Excellence
Discover the history of one of the nation's first cancer hospitals.
Read more »
Your Health Care Team
Our unique staff of health-care professionals focus solely on oncology.
Read more »
Featured Research News
(Mar 29, 2012)
“This year we have a remarkably strong showing in the survey,” says Glenn Rall, PhD, the associate professor who oversees the Postdoctoral Research Program at Fox Chase. “I think this reflects on our strong culture of mentoring, integration of basic and clinical research pertinent to cancer, and a common view that our postdoctoral fellows really are the engines of scientific progress.”
Fox Chase at the American Association for Cancer Research Annual Meeting 2012
(May 16, 2012)
(May 16, 2012)
"At no other cancer center will you find such a unique and intense set of collaborations: cross-disciplinary efforts in which ideas, inspiration, and insight flow from lab bench to bedside and back again."
Michael V. Seiden,
President,
Chief Executive Officer
New technologies and cancer treatments
Whether it's technology, a new surgical procedure or an improved chemotherapy option, our treatments are based on years of research. At Fox Chase, research takes place with an unusually high degree of interaction between our basic researchers and our doctors. For this reason, we're able to bring laboratory discoveries to the forefront of patient care.
New technologies and cancer treatments often are available at Fox Chase before becoming standard practice in the community.
Clinical trials
Combining research in many disciplines with patient care enables Fox Chase to translate new research findings into medical applications that may become models for improved cancer care.
At any one time, about 170 clinical trials of new prevention, diagnostic and treatment techniques are under way. Fox Chase is also involved in developing trials to test new drugs that may prevent cancer in high-risk individuals.
Find a Clinical Trial
Phase I clinical trials
Fox Chase has a special clinical-studies wing that includes a 10-bed special-care unit for patients participating in Phase I clinical trials. This unique unit is dedicated to clinical research for new cancer treatments such as developmental chemotherapy and studies of drug resistance.
For Information about cancer or